Sundowning and circadian rhythm disorders in dementia
- PMID: 17323834
Sundowning and circadian rhythm disorders in dementia
Abstract
Sleep disorders and disruptive nocturnal behaviours are commonly reported in people with senile dementia and present both a significant clinical problem and a cause of increased stress for caregivers. Neuronal degeneration of cholinergic Nucleus basalis Meynert (NBM) neurons promote rest-activity disturbance and Sundowning in Alzheimer's disease. NBM neurons modulate the activity of the mainly cholinergic suprachiasmatic nucleus (SCN) and the induction of NONREM sleep. Sundowning might be explained as a syndrome occurring when arousal is to be processed while the neocortex is already turned "off" to (NONREM) sleep. The therapeutic measures should thus primarily be aimed at the stimulation of the circadian system and enforcing "external Zeitgebers". Pharmacologically, application of cholinergic enhancers i.e. cholinesterase inhibitors and melatonin supports and should stabilize the weakened structures.
Similar articles
-
Circadian rhythm sleep disorders.Med Clin North Am. 2004 May;88(3):631-51, viii. doi: 10.1016/j.mcna.2004.01.010. Med Clin North Am. 2004. PMID: 15087208 Review. No abstract available.
-
Light therapy for behavioural and psychological symptoms of dementia.Int J Geriatr Psychiatry. 2004 Jun;19(6):516-22. doi: 10.1002/gps.1087. Int J Geriatr Psychiatry. 2004. PMID: 15211528 Review.
-
[Sleep disturbances in Alzheimer's disease and other dementias].Psychol Neuropsychiatr Vieil. 2010 Mar;8(1):15-23. doi: 10.1684/pnv.2010.0203. Psychol Neuropsychiatr Vieil. 2010. PMID: 20215095 Review. French.
-
[Sleep disorders and dementia].Praxis (Bern 1994). 1997 Aug 27;86(35):1343-9. Praxis (Bern 1994). 1997. PMID: 9381026 Review. German.
-
Clinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agent.Ann N Y Acad Sci. 2005 Dec;1057:327-36. doi: 10.1196/annals.1356.025. Ann N Y Acad Sci. 2005. PMID: 16399904
Cited by
-
Age-related changes in core body temperature and activity in triple-transgenic Alzheimer's disease (3xTgAD) mice.Dis Model Mech. 2013 Jan;6(1):160-70. doi: 10.1242/dmm.010173. Epub 2012 Aug 3. Dis Model Mech. 2013. PMID: 22864021 Free PMC article.
-
Temperature and toxic Tau in Alzheimer's disease: new insights.Temperature (Austin). 2015 Oct 19;2(4):491-8. doi: 10.1080/23328940.2015.1096438. eCollection 2015 Oct-Dec. Temperature (Austin). 2015. PMID: 27227069 Free PMC article. Review.
-
Clock-Enhancing Small Molecules and Potential Applications in Chronic Diseases and Aging.Front Neurol. 2017 Mar 15;8:100. doi: 10.3389/fneur.2017.00100. eCollection 2017. Front Neurol. 2017. PMID: 28360884 Free PMC article. Review.
-
β-amyloid infusion into lateral ventricle alters behavioral thermoregulation and attenuates acquired heat tolerance in rats.Temperature (Austin). 2015 Jun 3;2(3):418-24. doi: 10.1080/23328940.2015.1044635. eCollection 2015 Jul-Sep. Temperature (Austin). 2015. PMID: 27227055 Free PMC article.
-
Sleep duration, sleep efficiency, and amyloid β among cognitively healthy later-life adults: a systematic review and meta-analysis.BMC Geriatr. 2024 May 8;24(1):408. doi: 10.1186/s12877-024-05010-4. BMC Geriatr. 2024. PMID: 38714912 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical